Civil Rights Leaders & Drug Policy Experts Denounce Counterproductive Biden Recommendations on Fentanyl-Related Substances and Continued War on Drugs
Washington, DC — In response to the recommendations presented to Congress by the Office of National Drug Control Policy (ONDCP), the Department of Health and Human Services (HHS), and the Department of Justice (DOJ) on behalf of the Biden-Harris administration, civil rights and drug policy reform leaders, advocates, and experts including The Leadership Conference on Civil and Human Rights and Drug Policy Alliance issued the following response, attributable to Maritza Perez, Director of the Office of National Affairs at the Drug Policy Alliance: